Literature DB >> 33537939

Effects of Cannabinoid Agonists and Antagonists on Sleep in Laboratory Animals.

Maureen L Petrunich-Rutherford1, Michael W Calik2,3.   

Abstract

The cannabinoids are a family of chemical compounds that can be either synthesized or naturally derived. These compounds have been shown to modulate a wide variety of biological processes. In this chapter, the studies detailing the effects of cannabinoids on sleep in laboratory animals are reviewed. Both exogenous and endogenous cannabinoids generally appear to decrease wakefulness and alter rapid eye movement (REM) and non-REM sleep in animal models. In addition, cannabinoids potentiate the effects of sedative-hypnotic drugs. However, the individual contributions of each cannabinoid on sleep processes is more nuanced and may depend on the site of action in the central nervous system. Many studies investigating the mechanism of cannabinoid effects on sleep suggest that the effects of cannabinoids on sleep are mediated via cannabinoid receptors; however, some evidence suggests that some sleep effects may be elicited via non-cannabinoid receptor-dependent mechanisms. More research is necessary to fully elucidate the role of each compound in modulating sleep processes.

Entities:  

Keywords:  Cannabinoid receptors; Cannabinoids; In vivo; Laboratory animals; Sleep

Mesh:

Substances:

Year:  2021        PMID: 33537939     DOI: 10.1007/978-3-030-61663-2_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  105 in total

1.  Effect of cannabis indica on hexobarbital sleeping time and tissue respiration of rat brain.

Authors:  B C BOSE; A Q SAIFI; A W BHAGWAT
Journal:  Arch Int Pharmacodyn Ther       Date:  1963-02-01

2.  Effect of chronic marijuana administration of stages of primate sleep-wakefulness.

Authors:  P M Adams; E S Barratt
Journal:  Biol Psychiatry       Date:  1975-06       Impact factor: 13.382

3.  Chronic marijuana usage and sleep-wakefulness cycles in cats.

Authors:  E S Barratt; P M Adams
Journal:  Biol Psychiatry       Date:  1973-06       Impact factor: 13.382

4.  Phenitrone: ineffective blockade of (-)-trans- 9 -tetrahydrocannabinol in mice and dogs.

Authors:  H J Berger; J C Krantz
Journal:  J Pharm Pharmacol       Date:  1972-06       Impact factor: 3.765

5.  Behavioral and neurochemical effects of delta 9-tetrahydrocannabinol in rats.

Authors:  A K Bhattacharyya; C S Aulakh; S Pradhan; P Ghosh; S N Pradhan
Journal:  Neuropharmacology       Date:  1980-01       Impact factor: 5.250

6.  Effect of cannabidiol on cytochrome P-450 and hexobarbital sleep time.

Authors:  L M Bornheim; H K Borys; R Karler
Journal:  Biochem Pharmacol       Date:  1981-03-01       Impact factor: 5.858

7.  Development of tolerance to the prolongation of hexobarbitone sleeping time caused by cannabidiol.

Authors:  H K Borys; G B Ingall; R Karler
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

8.  Characterization of the hypnotic properties of oleamide.

Authors:  A S Basile; L Hanus; W B Mendelson
Journal:  Neuroreport       Date:  1999-04-06       Impact factor: 1.837

9.  The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors.

Authors:  R Baur; J Gertsch; E Sigel
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

10.  Effects of acute delta 9-THC administration on EEG and EEG power spectra in the rat.

Authors:  M Buonamici; G A Young; N Khazan
Journal:  Neuropharmacology       Date:  1982-08       Impact factor: 5.250

View more
  2 in total

Review 1.  Is There a Place for Medicinal Cannabis in Treating Patients with Sleep Disorders? What We Know so Far.

Authors:  Kathleen J Maddison; Christopher Kosky; Jennifer H Walsh
Journal:  Nat Sci Sleep       Date:  2022-05-18

2.  In vivo Evidence for Brain Region-Specific Molecular Interactions Between Cannabinoid and Orexin Receptors.

Authors:  Hye Ji J Kim; Ayat Zagzoog; Anna Maria Smolyakova; Udoka C Ezeaka; Michael J Benko; Teagan Holt; Robert B Laprairie
Journal:  Front Neurosci       Date:  2021-12-21       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.